Event-Driven Stocks

Diadexus, Inc.

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs● 2 good● 6 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY15FY14FY13FY12FY11FY10
Revenue$5.5M$5.4M$24.9M$20.8M$16.4M$11.8M
Operating income−$508,000−$3.9M−$2.0M−$2.4M−$7.8M−$8.6M
Net income−$970,000−$4.1M−$2.2M−$2.8M−$7.5M−$8.4M
Total assets$13.2M$22.3M$23.6M$20.5M$24.4M$26.1M
Total liabilities$17.9M$21.4M$16.1M$11.6M$13.2M$8.2M
Equity−$4.7M$846,000$7.5M$8.9M$11.1M$17.8M
EPS (diluted)——————
Shares out.56.9M54.8M53.9M53.1M53.1M53.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2015
Operating margin
−9.2%
Net margin
−17.6%
Return on equity
20.6%
Return on assets
−7.4%
Return on capital (ROCE)
—
Liabilities / assets
135.8%
Debt / equity
—
Book value / share
$-0.08
Revenue growth (YoY)
1.7%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2015
Altman Z″ (distress)
-56.88distress
Accruals / assets
34.6%high accruals
Beneish M-Score
-1.31elevated
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
32
/ 100
Profitability 25Growth 100Catalyst 33Earnings quality 0Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 6 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
1 acquisitions0 disposalsnet +218,182 shares · last 1
InsiderDateTypeSharesPrice
Rafield Lori F PhdOfficer — Interim CEOFeb 5, 2015Grant218,182$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)